McKesson Co. (MCK) Receives $174.16 Consensus Price Target from Analysts
McKesson Co. (NYSE:MCK) has been given a consensus recommendation of “Hold” by the twenty analysts that are covering the stock. Two analysts have rated the stock with a sell recommendation, eleven have given a hold recommendation, six have issued a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $172.91.
Several analysts have recently commented on the company. Leerink Swann set a $140.00 price objective on McKesson and gave the company a “hold” rating in a report on Friday. Vetr upgraded McKesson from a “buy” rating to a “strong-buy” rating and set a $157.86 price objective for the company in a report on Tuesday. Evercore ISI reiterated an “outperform” rating and set a $166.00 price objective on shares of McKesson in a report on Monday. Needham & Company LLC assumed coverage on McKesson in a report on Tuesday, April 4th. They set a “hold” rating for the company. Finally, Citigroup Inc upped their target price on McKesson from $169.00 to $175.00 and gave the company a “buy” rating in a research report on Monday, March 6th.
WARNING: “McKesson Co. (MCK) Receives $174.16 Consensus Price Target from Analysts” was first published by Financial Market News and is the property of of Financial Market News. If you are viewing this news story on another site, it was stolen and reposted in violation of international trademark & copyright law. The original version of this news story can be read at https://www.financial-market-news.com/2017/04/21/mckesson-co-mck-receives-174-16-consensus-price-target-from-analysts.html.
McKesson (NYSE:MCK) traded down 1.26% on Tuesday, hitting $135.92. The stock had a trading volume of 1,336,767 shares. The firm has a market capitalization of $28.82 billion, a price-to-earnings ratio of 16.13 and a beta of 1.06. The stock’s 50-day moving average is $146.36 and its 200 day moving average is $146.43. McKesson has a 1-year low of $114.53 and a 1-year high of $199.43.
McKesson (NYSE:MCK) last issued its quarterly earnings data on Wednesday, January 25th. The company reported $3.03 EPS for the quarter, beating the consensus estimate of $2.95 by $0.08. McKesson had a return on equity of 30.05% and a net margin of 0.97%. The firm earned $50.13 billion during the quarter, compared to analyst estimates of $50.71 billion. During the same quarter in the prior year, the business posted $3.18 EPS. The business’s revenue for the quarter was up 4.7% compared to the same quarter last year. On average, equities research analysts predict that McKesson will post $12.62 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Monday, April 3rd. Stockholders of record on Wednesday, March 1st were given a dividend of $0.28 per share. This represents a $1.12 dividend on an annualized basis and a dividend yield of 0.82%. The ex-dividend date of this dividend was Monday, February 27th. McKesson’s dividend payout ratio (DPR) is presently 13.25%.
In other news, Chairman John H. Hammergren sold 100,500 shares of the firm’s stock in a transaction dated Wednesday, March 29th. The stock was sold at an average price of $150.44, for a total transaction of $15,119,220.00. Following the sale, the chairman now directly owns 22,390 shares in the company, valued at approximately $3,368,351.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.15% of the stock is owned by company insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of MCK. Orrstown Financial Services Inc. raised its position in shares of McKesson by 16.3% in the first quarter. Orrstown Financial Services Inc. now owns 715 shares of the company’s stock worth $106,000 after buying an additional 100 shares in the last quarter. SRB Corp raised its position in shares of McKesson by 3.4% in the third quarter. SRB Corp now owns 814 shares of the company’s stock worth $136,000 after buying an additional 27 shares in the last quarter. Tompkins Financial Corp raised its position in shares of McKesson by 8.8% in the first quarter. Tompkins Financial Corp now owns 962 shares of the company’s stock worth $151,000 after buying an additional 78 shares in the last quarter. Independent Advisor Alliance bought a new position in shares of McKesson during the fourth quarter worth $161,000. Finally, State of Alaska Department of Revenue raised its position in shares of McKesson by 6.9% in the third quarter. State of Alaska Department of Revenue now owns 1,192 shares of the company’s stock worth $198,000 after buying an additional 77 shares in the last quarter. 87.81% of the stock is currently owned by hedge funds and other institutional investors.
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally.
Receive News & Ratings for McKesson Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson Co. and related companies with MarketBeat.com's FREE daily email newsletter.